IM8 Raises 2026 Revenue Guidance to $190M-$210M
The company said, "Based on this trajectory, we currently expect Q2 2026 revenues of approximately $46 million to $48 million, with IM8 contributing approximately $44 million to $46 million - representing approximately 33% sequential quarterly growth in IM8 revenue. We are also raising our full-year 2026 IM8 revenue guidance to $190 million to $210 million, from our prior range of $180 million to $200 million. The strength of our underlying unit economics, the global pull we are seeing from consumers across more than 40 markets, and the upside in new marketing channels gives us strong conviction. Looking ahead, I am especially excited about our product roadmap. In Q4 2026, IM8 plans to launch new offerings in three meaningful categories with very large addressable markets - hydration, creatine and kids' gummies - extending the brand into high-growth segments and giving our global community more ways to make IM8 part of their daily lives. Each of these launches is grounded in the same standard that defines IM8: world-class science, premium ingredients and genuine consumer demand. What we have built with David Beckham, our elite roster of athlete partners, and our world-class scientific advisory board is becoming a category-defining global health brand. Q1 proved the model. Q2 is proving the acceleration. The rest of 2026 will demonstrate the scale of the opportunity ahead."
